Author

M. M. Murata

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. E. Giuliano· 1 shared D. Di Vizio· 1 shared E. M. Posadas· 1 shared F. Igari· 1 shared H. Tanaka· 1 shared L. Kong· 1 shared L. Mouakkad· 1 shared M. A. Digman· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. E. Giuliano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNA

M. M. Murata, F. Igari, R. Urbanowicz, L. Mouakkad, S. Kim, Z. Chen, D. Di Vizio, E. M. Posadas, A. E. Giuliano, H. Tanaka

The paper introduces GAPF-seq, a method to detect structural variants in cfDNA, achieving high accuracy in distinguishing tumors from controls.

bioRxiv · Oct 25, 2023 · PreprintCancer Biology

Restoring p53 Function and Silencing REV3L Suppresses the Cancerous Metabolic Phenotype in Cisplatin Treated Human Non-Small Lung Carcinoma Cells

L. Kong, M. M. Murata, M. A. Digman

This study shows that restoring p53 and silencing REV3L reduces cancerous metabolic traits and increases cell death in cisplatin-treated lung cancer cells.

bioRxiv · Oct 10, 2017Cancer Biology